Concurrent injection of cold antibody allows PET imaging of orthotopic pancreatic tumor with "Cu -labeled anti -PD-L1

被引：0
|
作者：
Wen, Xiaoxia [3 ]
Zhao, Jun [3 ]
Wen, Xiaofei [1 ]
Shi, Sixiang [3 ]
Li, Tingting [2 ]
Li, Chun [3 ]
机构：
[1] Harbin Med Univ, Hosp 4, Harbin, Heilongjiang, Peoples R China
[2] Univ Elect Sci & Technol China, Chengdu, Sichuan, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
607
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody
    Camilla Christensen
    Lotte K. Kristensen
    Maria Z. Alfsen
    Carsten H. Nielsen
    Andreas Kjaer
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 1302 - 1313
  • [32] Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody
    Christensen, Camilla
    Kristensen, Lotte K.
    Alfsen, Maria Z.
    Nielsen, Carsten H.
    Kjaer, Andreas
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (05) : 1302 - 1313
  • [33] Altering the tumor microenvironment to improve immunotherapy: Molecular imaging of PD-L1 in pancreatic cancer
    Henry, Kelly
    Davydova, Maria
    Dilling, Thomas
    Fox, Ian
    Lewis, Jason
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [34] A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
    Albu, Diana I.
    Wolf, Benjamin J.
    Qin, Yan
    Wang, Xianzhe
    Ulumben, Amy Daniel
    Su, Mei
    Li, Vivian
    Ding, Eirene
    Gonzalo, Jose Angel
    Kong, Jason
    Jadhav, Ruturaj
    Kuklin, Nelly
    Visintin, Alberto
    Gong, Bing
    Schuetz, Thomas J.
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [35] PET Imaging of PD-L1 Expression in NSCLC: Pharmacokinetic Comparison of an Antibody and its Fab Fragment
    Bouleau, A.
    Nozach, H.
    Richard, M.
    Dubois, S.
    Torquet, G.
    Kuhnast, B.
    Maillere, B.
    Lebon, V.
    Truillet, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S160 - S160
  • [36] First-in-human PET imaging with the PD-L1 antibody 89Zr-atezolizumab
    Bensch, Frederike
    van der Veen, Elly
    Jorritsma, Annelies
    Lub-de Hooge, Marjolijn
    Boellaard, Ronald
    Oosting, Sjoukje
    Schroder, Carolien
    Hiltermann, Jeroen
    van der Wekken, Anthonie
    Groen, Harry
    Fine, Bernard
    McKnight, Nathan
    Bohorquez, Sandra Sanabria
    Williams, Simon
    Veronese, Luisa
    Mancao, Christoph
    Brouwers, Adrienne H.
    de Vries, Elisabeth
    CANCER RESEARCH, 2017, 77
  • [37] PET imaging of PD-L1 overexpressing tumors with a 68Ga labeled D-dodecapeptide
    Hu, Kuan
    Xie, Lin
    Hanyu, Masayuki
    Zhang, Yiding
    Zhang, Ming-Rong
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : S2 - S2
  • [38] Noninvasive PET imaging of the PD-1/PD-L1 checkpoint in naive and irradiated tumor-bearing mice
    Hettich, M.
    Braun, F.
    Niedermann, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 38 - 38
  • [39] Noninvasive PET imaging of the PD-1/PD-L1 checkpoint in naive and irradiated tumor-bearing mice
    Niedermann, G.
    Hettich, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [40] Lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1/PD-L1 blockade therapy-resistant tumor
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Dhawan, Deepika
    Knapp, Deborah W.
    Lim, Seung-Oe
    MOLECULAR THERAPY, 2025, 33 (02)
12345